These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5720723)

  • 1. [The effect of Halidor on serum lipid fractions in patients with coronary disease and cerebrovascular sclerosis].
    Krámer M; Keller L; Molnár G
    Orv Hetil; 1968 May; 109(21):Suppl:42-3. PubMed ID: 5720723
    [No Abstract]   [Full Text] [Related]  

  • 2. The fatty acid composition of serum total lipids and lipid fractions in coronary heart disease and cerebral atherosclerosis.
    Abdel Hay A; Kramer M; Keller L; Retsagi G
    J Egypt Med Assoc; 1970; 53(5):309-20. PubMed ID: 5506287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fatty acid composition of serum lipid fractions in coronary sclerosis and cerebral sclerosis].
    Keller L; Rétsági G; Abdel Hay A; Madarász M; Krámer M
    Orv Hetil; 1966 Nov; 107(47):2216-9. PubMed ID: 5978929
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of blood lipids in coronary sclerosis and cerebrosclerosis].
    Keller L; Fischer J; Farádi A
    Orv Hetil; 1974 Jun; 115(23):1323-7. PubMed ID: 4840692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ophthalmologic use of Halidor. Ophthalmo-dynamometric registration of its effect on the cerebral vessels].
    Födö V
    Orv Hetil; 1968 May; 109(21):Suppl:49-52. PubMed ID: 5720725
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Halidor on cerebral hemodynamics and metabolism in ischemic cerebral circulatory disorders].
    Hadjiev D; Ganev G
    Orv Hetil; 1968 May; 109(21):Suppl:37-40. PubMed ID: 5720721
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electroencephalographic and rheoencephalographic studies with Halidor].
    Horányi B; Hasznos T; Moussong-Kovács E
    Orv Hetil; 1968 May; 109(21):Suppl:33-6. PubMed ID: 5720720
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipids, high density lipoprotein cholesterol and mortality in coronary and cerebral arteriosclerosis].
    Nebieridze DV; Zhukovskiĭ GS; Deev AD; Akhmeteli MA; Zadoia AA
    Ter Arkh; 1981; 53(1):60-2. PubMed ID: 7221911
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relations between the degree of arteriosclerosis and trace element and lipid parameters].
    Voigt H; Reuter W; Peters HJ; Köhler H; Herrmann W
    Z Gesamte Hyg; 1984 Jun; 30(6):321-2. PubMed ID: 6475156
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum haptoglobin level in atherosclerosis.
    Székely J; Simon A; Horváth E
    Acta Med Acad Sci Hung; 1971; 28(1):19-26. PubMed ID: 5133496
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Halidor on the redistribution of the minute volume].
    Solti F; Krasznai I; Iskum M; Gyertyánffy G
    Orv Hetil; 1968 May; 109(21):Suppl:24-5. PubMed ID: 5720717
    [No Abstract]   [Full Text] [Related]  

  • 12. Data concerning blood lipid levels in cerebral atherosclerosis.
    Sterman-Marinchescu C; Stefănescu E; Ciurea E; Roman E; Ciucă V; Ologeanu M
    Neurol Psychiatr (Bucur); 1976; 14(4):. PubMed ID: 191901
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the action of Halidor on the circulation in the extremities].
    Solti F
    Orv Hetil; 1968 May; 109(21):Suppl:21-4. PubMed ID: 5720716
    [No Abstract]   [Full Text] [Related]  

  • 14. [Additional pharmacologic studies on the EGYT-201 compound (Halidor)].
    Kovács I
    Orv Hetil; 1968 May; 109(21):Suppl:12-4. PubMed ID: 5720712
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis].
    Caruzzo C; Enrico-Bena L; Carnaghi R
    Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mortality in men 40 to 59 years old from coronary and cerebral arteriosclerosis with varying cholesterol and triglyceride levels in the blood].
    Nebieridze DV; Zhukovskiĭ GS; Akhmeteli MA; Gerasimova EN; Deev AD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):78-81. PubMed ID: 7259871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipid fractions and risk of coronary heart disease. The Framingham study.
    Kannel WB; Castelli WP; McNamara PM
    Minn Med; 1969 Aug; 52(8):1225-30. PubMed ID: 5804989
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phenotyping of hyperlipoproteinemias in atherosclerosis patients treated at Kislovodsk].
    Shumskaia VI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1978; (3):33-6. PubMed ID: 149419
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum lipids in normal subjects, coronary heart disease and cerebrovascular disease.
    Rattanapanone V; Jiviriyawat Y
    J Med Assoc Thai; 1983 Dec; 66(12):779-84. PubMed ID: 6676441
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of Halidor on brain hemodynamics and oxidative metabolism].
    Saratikov AS; Usov LA; Filimonova LT; Gorshkova VK; Dmitrienko VF
    Farmakol Toksikol; 1971; 34(6):668-71. PubMed ID: 5139783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.